肾细胞癌
新生血管
瞬时受体电位通道
癌症研究
口腔1
瞬态(计算机编程)
医学
肾癌
血管生成
受体
肿瘤科
内科学
计算机科学
刺激1
钙
操作系统
作者
Francesco Moccia,Silvia Dragoni,Valentina Poletto,Vittorio Rosti,Franco Tanzi,Carlo Ganini,Camillo Porta
出处
期刊:Anti-cancer Agents in Medicinal Chemistry
[Bentham Science]
日期:2014-01-31
卷期号:14 (2): 296-312
被引量:48
标识
DOI:10.2174/18715206113139990315
摘要
The term “angiogenic switch” describes one of the earlier events of tumorigenesis, that occurs when the balance between proand anti-angiogenic factors shifts towards a pro-angiogenic outcome. This leads to the transition from a microscopic indolent lesion to a macroscopic and vascularised primary tumor, that may eventually metastasize and spread to distant sites. The molecular mechanisms underlying such a critical step in the carcinogenetic process have been extensively investigated. Both local endothelial cells (ECs) and endothelial progenitor cells (EPCs), recruited from bone marrow, have been implicated in the angiogenic switch, which is ultimately triggered by a plethora of growth factors released by cancer cells, pivotal among which is vascular endothelial growth factor (VEGF); indeed, VEGF both activates ECs nearby the growing tumor, and leads to EPC mobilization into the circulation. In kidney, in particular, the frequent mutation of the Von Hippel Lindau tumor suppressor gene leads to an overproduction of pro-angiogenic factors which makes this neoplasm quite sensitive to antiangiogenic drugs. However, it is now evident that the use of VEGF(Rs) inhibitors in everyday clinical practice is not as effective as observed in murine models. The investigation of alternative signaling pathways involved in the angiogenic switch is, therefore, imperative in order to induce tumor regression whereby preventing harmful drawback consequences. Ca2+ entry across the plasma membrane has long been known to stimulate mature ECs to undergo angiogenesis. Recent work from several groups worldwide has then outlined that members of the Transient Receptor Potential (TRP) super-family of cationic channels and Orai1 provide the pathway for such proangiogenic Ca2+ signal. In addition, Canonical TRP 1 (TRPC1) and Orai1 channels control proliferation and tubulogenesis in both normal EPCs and EPCs isolated from peripheral blood of tumor patients. As a consequence, TRP channels and Orai1 might serve as novel molecular targets to develop alternative and more effective strategies of angiogenesis inhibition. Keywords: Angiogenesis, endothelial cells, endothelial progenitor cells, store-operated Ca2+ entry, TRP channels, tumor.
科研通智能强力驱动
Strongly Powered by AbleSci AI